“Let's get started with the stocks that sold off hard today, because I think it's really important, because you know most, if not all, of these companies.
Keep Reading →
May 16 - Hedge Funds, News
“When interest rates go up, even if they go up just a little, you can see lots of very good well-known stocks with juicy dividends just get pummeled.
Keep Reading →
May 16 - Hedge Funds, News
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
Keep Reading →
May 12 - Hedge Funds, Industries, News
Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment strategies.
Keep Reading →
May 9 - Dividend Stocks, Hedge Funds, News
“Alright, look, lately, we can’t go a day without hearing some widespread misperceptions about stock ownership. I gotta tell you, I think it’s infuriating.
Keep Reading →
May 4 - Hedge Funds, News
Jim Cramer in a latest program on CNBC talked about the latest signs of de-escalation in trade wars between the US and China and told investors that even bear market rallies could...
Keep Reading →
April 30 - Hedge Funds, News
Dividend stocks are increasingly popular with both every day and billionaire investors.
Keep Reading →
April 27 - Dividend Stocks, Hedge Funds, News
Bill Strazzullo, Bell Curve Trading chief market strategist, said in a latest program on CNBC that the market isn’t done going down and urged investors not to buy every dip ...
Keep Reading →
April 27 - Hedge Funds, News
Bristol-Myers Squibb Company (NYSE:BMY) Q1 2025 Earnings Call Transcript April 24, 2025Bristol-Myers Squibb Company beats earnings expectations.
Keep Reading →
April 25 - News, Transcripts
Value stocks are enjoying a rare period of strength amid this year’s broader market downturn.
Keep Reading →
April 23 - Dividend Stocks, Hedge Funds, News
Threats of an impending recession are looming over the stock market due to Trump's tariffs and macroeconomic uncertainty.
Keep Reading →
April 22 - Hedge Funds, News
The stock market has been experiencing volatility and has quickly shifted from the post-election highs to being priced for recession.
Keep Reading →
April 16 - Hedge Funds, News
With big American pharmaceutical corporations always searching for medications in China, the US pharmaceutical industry is going through a unique trend never seen before.
Keep Reading →
April 14 - Hedge Funds, News
Dividends, though sometimes underappreciated, have significantly contributed to long-term investor gains.
Keep Reading →
April 14 - Dividend Stocks, Hedge Funds, News
Some experts view medical, healthcare, and big pharma stocks as immune from trade carnage, making them a safe haven amid the uncertainty brought about by Trump's tariffs.
Keep Reading →
April 10 - Hedge Funds, Industries, News
Amid growing concerns about economic growth and President Trump's tariffs, investors have been seeking safer investment options.
Keep Reading →
April 9 - Dividend Stocks, Hedge Funds, News
On his appearance on CNBC's Squawk on the Street on Thursday, Jim Cramer commented on the global response to President Trump's tariffs.
Keep Reading →
April 7 - Market Movers, News
Dividend investing appears to be a simple strategy on the surface, but in reality, it requires a much deeper analysis.
Keep Reading →
March 31 - Hedge Funds, News
Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and AI.
Keep Reading →
March 30 - Hedge Funds, News
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed his takeaways from last week's GTC conference.
Keep Reading →
March 27 - News
Billionaire investor and CEO of Berkshire Hathaway Warren Buffett sold a record $134 billion worth of stock in 2024.
Keep Reading →
March 20 - Hedge Funds, News
The US healthcare sector has been at the forefront since the emergence of COVID-19 in 2020, leading to a significant transformation in the industry.
Keep Reading →
March 20 - Dividend Stocks, Hedge Funds, News
On February 21, Jared Holz, Mizuho Securities America's healthcare sector strategist, appeared on CNBC to discuss Trump's tariffs and their effects on the American pharma sector...
Keep Reading →
March 17 - Hedge Funds, Industries, News
Identifying undervalued stocks in an uncertain market environment is both a challenge and an opportunity for investors.
Keep Reading →
March 17 - Hedge Funds, News
We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BMY.
Keep Reading →
March 17 - News, Stock Analysis
Value investing has long been a preferred strategy among investors, largely influenced by Warren Buffett, who continues to seek out stocks he believes are trading below their ...
Keep Reading →
March 14 - Dividend Stocks, Hedge Funds, News
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
Keep Reading →
March 11 - Hedge Funds, Industries, News
Dividend stocks have taken a backseat in the market as technology and AI-driven equities have soared to record highs.
Keep Reading →
March 7 - Dividend Stocks, Hedge Funds, News
Value investing has remained a favored approach among investors for years, largely popularized by Warren Buffett, who continues to focus on stocks he believes are undervalued ...
Keep Reading →
March 6 - Dividend Stocks, Hedge Funds, News
Jim Cramer in a latest program on CNBC said that pain is “inevitable” in the stock market as investors go through the volatility infused by the latest tariffs announced by...
Keep Reading →
March 5 - Hedge Funds, News
Dividend stocks have been overshadowed in the market as tech and AI-related equities have surged to record levels.
Keep Reading →
March 3 - Dividend Stocks, Hedge Funds, News
The stocks showcased initial enthusiasm post Trump’s election, as the S&P 500 saw an increase of 2.5% on the day after the November vote, says U.S. Bank.
Keep Reading →
March 3 - Hedge Funds, News
Stock market investors have enjoyed strong annual returns over the past two years, but analysts caution that 2025 may not deliver a repeat performance.
Keep Reading →
February 28 - Dividend Stocks, Hedge Funds, News
There is a common misconception that dividend stocks are primarily suited for those nearing retirement. However, this is not the case.
Keep Reading →
February 25 - Dividend Stocks, Hedge Funds, News
Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for medicines in China.
Keep Reading →
February 16 - Hedge Funds, Industries, News
Jim Cramer, the host of Mad Money, recently pointed out a significant gap in the American education system, emphasizing that financial literacy is rarely taught in schools, from...
Keep Reading →
February 12 - Hedge Funds, News
In his latest appearance on CNBC's Squawk on the Street, Jim Cramer discussed President Trump's tariffs on Mexico and their impact on the car industry.
Keep Reading →
February 11 - News
In this article, we will take a look at 12 stocks that Jim Cramer discussed 6 months ago during his show on July 29, 2024, and examine whether he was right or wrong about those...
Keep Reading →
February 7 - Hedge Funds, News
Bristol-Myers Squibb Company (NYSE:BMY) Q4 2024 Earnings Call Transcript February 6, 2025Bristol-Myers Squibb Company beats earnings expectations.
Keep Reading →
February 7 - News, Transcripts
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the potential impact on Wall Street from President Trump's potential actions against Denmark, Panama...
Keep Reading →
February 5 - News
Russell Investments continues to monitor and analyze the potential for policy changes in President Trump's second term in office.
Keep Reading →
February 5 - Hedge Funds, News
Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which will be dominated by earnings reports from various ...
Keep Reading →
February 3 - Hedge Funds, News
As the DeepSeek craze ignites a sell-off in the tech sector, investors are weighing the implications of the downturn in the long term.
Keep Reading →
January 31 - Hedge Funds, News
On the day that Wall Street's favorite AI GPU stock bled 17% in the wake of investors panicking about Chinese AI startup DeepSeek's low development costs for AI, Jim Cramer had...
Keep Reading →
January 29 - News
Blue chip stocks have long been considered the gold standard of investments, offering a combination of steady growth, consistent dividends, and a reputation for weathering economic...
Keep Reading →
January 29 - Hedge Funds, News
The US stock market is often regarded as one of the most reliable and resilient financial markets in the world.
Keep Reading →
January 28 - Hedge Funds, News
Dividend stocks, while popular among investors, have been underperforming for a while.
Keep Reading →
January 21 - Dividend Stocks, Hedge Funds, News
Dividend stocks have been investors’ favorites for a long time now. Over the years, these equities have performed better than the broader market.
Keep Reading →
January 20 - Dividend Stocks, Hedge Funds, News
We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Disruptive analytics’ Substack by Magnus Ofstad.
Keep Reading →
January 20 - News, Stock Analysis
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the devastation ushered in by the California wildfire calamity, social media CEO Mark Zuckerberg...
Keep Reading →
January 18 - News